Sarepta Therapeutics, INC. (SRPT) SEC Filings — 2024

Filings

• Sarepta Therapeutics Enters Material Definitive Agreement — 8-K · Nov 26, 2024
• Sarepta Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Sarepta Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Sarepta Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
• Sarepta Therapeutics Appoints New Director — 8-K · Sep 16, 2024
• Sarepta Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
• Sarepta Therapeutics Appoints New CMO, Elects Directors — 8-K · Jun 7, 2024
• Sarepta Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Jun 7, 2024
• Sarepta Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
• Sarepta Therapeutics, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 24, 2024
• Sarepta Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
• Janus Henderson Maintains >5% Stake in Sarepta Therapeutics — SC 13G/A · Feb 13, 2024
• Vanguard Trims Sarepta Stake to 11.2% as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024
• Capital International Investors Takes 8.0% Stake in Sarepta — SC 13G · Feb 9, 2024
• BlackRock Amends Sarepta Stake, Maintains Passive Position — SC 13G/A · Jan 26, 2024
• Sarepta Files 8-K on Operations & Financial Condition — 8-K · Jan 8, 2024